Epitope-based universal vaccine for Human T-lymphotropic virus-1 (HTLV-1).

Epitope-based universal vaccine for Human T-lymphotropic virus-1 (HTLV-1).

Human T-cell leukemia virus type 1 (HTLV-1) was the first oncogenic human retrovirus identified in humans which infects at least 10-15 million people worldwide. Large HTLV-1 endemic areas exist in Southern Japan, the Caribbean, Central and South America, the Middle East, Melanesia, and equatorial re...

Full description

Bibliographic Details
Main Authors:	Md Thosif Raza, Shagufta Mizan, Farhana Yasmin, Al-Shahriar Akash, Shah Md Shahik
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2021-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0248001

Similar Items

Human T-Lymphotropic Virus Type 1 (HTLV-1) and Regulatory T Cells in HTLV-1-Associated Neuroinflammatory Disease
by: Yoshihisa Yamano, et al.
Published: (2011-08-01)

Human T-lymphotropic virus type 1(HTLV-1) associated infective dermatitis
by: Hlela, C
Published: (2011)

Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis
by: Patrick L. Green, et al.
Published: (2010-09-01)

Immunoinformatics approach to designing a multi-epitope vaccine against Saint Louis Encephalitis Virus
by: Md. Shakhawat Hossain, et al.
Published: (2021-01-01)

Cellular tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2)
by: Green Patrick L, et al.
Published: (2011-06-01)

Histopathologic differences between human T-lymphotropic virus type 1 (HTLV-1)-positive and HTLV-1-negative polymyositis
by: Inamori Yukie, et al.
Published: (2011-06-01)

Provirus Mutations of Human T-Lymphotropic Virus 1 and 2 (HTLV-1 and HTLV-2) in HIV-1-Coinfected Individuals
by: Karoline Rodrigues Campos, et al.
Published: (2020-10-01)

Editorial: Prevention and control of human T lymphotropic viruses 1 and 2 (HTLV-1/2)
by: Luiz Fernando Almeida Machado, et al.
Published: (2022-08-01)

Gastric strongyloidiasis and infection by the human T cell lymphotropic virus type 1 (HTLV-1)
by: José Roberto Lambertucci, et al.
Published: (2003-07-01)

Predicting and Designing Epitope Ensemble Vaccines against HTLV-1
by: Alam Saruar, et al.
Published: (2020-01-01)

Human T-cell lymphotropic virus type 1 (HTLV-1) proposed vaccines: a systematic review of preclinical and clinical studies
by: Niloofar Seighali, et al.
Published: (2023-05-01)

Radiographic aspects in individuals infected by human T-lymphotropic virus type 1 (HTLV-1) with joint pain
by: João Marcos da Silva Carvalho, et al.
Published: (2022-08-01)

Leukotrienes are upregulated and associated with human T-lymphotropic virus type 1 (HTLV-1)-associated neuroinflammatory disease.
by: Bruno Caetano Trindade, et al.
Published: (2012-01-01)

Factors associated with pain in individuals infected by human T-cell lymphotropic virus type 1 (HTLV-1)
by: Dislene N. dos Santos, et al.
Published: (2017-03-01)

Spinal cord hypometabolism associated with infection by human T-cell lymphotropic virus type 1(HTLV-1).
by: Luiz C F Romanelli, et al.
Published: (2018-08-01)

Human T-Lymphotropic Virus Type 1 (Htlv-1): a new subgroup within the cosmopolitan subtype
by: Biglione Mirna, et al.
Published: (2011-06-01)

Human T-cell lymphotropic virus type 1 (HTLV-1)-associated bronchioloalveolar disorder required differentiation from fibrotic chronic hypersensitivity pneumonitis
by: Tomonori Chikasue, MD, et al.
Published: (2022-07-01)

Work-Related Human T-lymphotropic Virus 1 and 2 (HTLV-1/2) Infection: A Systematic Review
by: Angela Stufano, et al.
Published: (2021-09-01)

Molecular epidemiology of endemic Human T-Lymphotropic virus 1 (HTLV-1) in a community in rural Guinea-Bissau
by: Gonçalves Nato, et al.
Published: (2011-06-01)

WHO antibody reference panel for donor screening assays that detect antibodies to human T-lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2)
by: Cowan Elliot P, et al.
Published: (2011-06-01)

Genetic characterization of human T-cell lymphotropic virus type 1 in Mozambique: transcontinental lineages drive the HTLV-1 endemic.
by: Ana Carolina P Vicente, et al.
Published: (2011-04-01)

An immunoinformatics and extended molecular dynamics approach for designing a polyvalent vaccine against multiple strains of Human T-lymphotropic virus (HTLV).
by: Abu Tayab Moin, et al.
Published: (2023-01-01)

The role of human T-lymphotropic virus (HTLV) in cardiovascular diseases: A review of literature
by: Samaneh Abolbashari, et al.
Published: (2018-07-01)

Low genetic diversity of the Human T-cell Lymphotropic Virus (HTLV-1) in an endemic area of the Brazilian Amazon basin.
by: Akim Felipe Santos Nobre, et al.
Published: (2018-01-01)

Making the invisible visible: searching for human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in Brazilian patients with viral hepatitis B and C
by: Adele Caterino-de-Araujo, et al.

Comparative performances of serologic and molecular assays for detecting human T lymphotropic virus type 1 and type 2 (HTLV-1 and HTLV-2) in patients infected with human immunodeficiency virus type 1 (HIV-1)
by: Karoline Rodrigues Campos, et al.
Published: (2017-05-01)

Human T-Cell Lymphotropic Virus Type I (HTLV-1): implications for autoimmune diseases<br> Vírus linfotrópico de células T humano tipo 1 (HTLV-1): implicações em doenças autoimunes
by: Dênis Augusto Santana Reis, et al.
Published: (2012-06-01)

Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa
by: Mahieux Renaud, et al.
Published: (2005-05-01)

Distribution of Human T-Lymphotropic Virus (HTLV) and Hepatitis C Co-infection in Bahia, Brazil.
by: Felicidade Mota Pereira, et al.
Published: (2020-01-01)

The reasons to include the serology of human T-lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in the clinical follow-up of patients with viral hepatitis B and C in Brazil.
by: Karoline Rodrigues Campos, et al.
Published: (2020-05-01)

HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.
by: Jeffery, K, et al.
Published: (1999)

Human T-lymphotropic virus type 1 (HTLV-1) infection and spastic paraparesis. Advances and diagnosis 35 years after its discovery
by: Rivera-Caldón, Cristhian Camilo, et al.
Published: (2017-04-01)

Lesões dermatológicas em pacientes infectados pelo vírus linfotrópico humano de células T do tipo 1 (HTLV-1) Dermatologic lesions in patients infected with the human T-cell lymphotropic vírus type 1 (HTLV-1)
by: Vandack Nobre, et al.
Published: (2005-02-01)

Diversity of HLA-A2-Restricted and Immunodominant Epitope Repertoire of Human T-Lymphotropic Virus Type 1 (HTLV-1) Tax Protein: Novel Insights among N-Terminal, Central and C-Terminal Regions
by: Thaiza Aline Pereira-Santos, et al.
Published: (2023-03-01)

In silico structure analysis and epitope prediction of E3 CR1-beta protein of Human Adenovirus E for vaccine design
by: Noman Ibna Amin Patwary, et al.
Published: (2016-12-01)

Serologic Prevalence of Human T-Lymphotropic Virus (HTLV) among major Thalassemic Patients in Kermanshah 2010
by: Mohammad Erfan Zare, et al.
Published: (2011-10-01)

Serologic Prevalence of Human T-Lymphotropic Virus (HTLV) among major Thalassemic Patients in Kermanshah 2010
by: Keighobad Ghadiri, et al.
Published: (2011-12-01)

Brazilian Protocol for Sexually Transmitted Infections 2020: human T-cell lymphotropic virus (HTLV) infection
by: Carolina Rosadas, et al.
Published: (2021-05-01)

Screening for Human T-Cell Lymphotropic Virus (HTLV) in Pregnant Women in the Peruvian Amazon and Systematic Review with Meta-Analysis of HTLV Infection in Peru
by: José-Manuel Ramos-Rincón, et al.
Published: (2021-02-01)

Human T-lymphotropic virus type 1 (HTLV-1) prevalence and quantitative detection of DNA proviral load in individuals with indeterminate/positive serological results
by: Bon Isabella, et al.
Published: (2006-03-01)